$CPAC

Cementos Pacasmayo S.A.A. (NYSE:CPAC) Sees Large Growth in Short Interest

Cementos Pacasmayo (NYSE:CPAC) reported short interest of 26,746 shares as of May 15, up 121.5% from 12,077 on April 30, with a days-to-cover ratio of 1.5 based on average volume. CPAC traded down 1.3% to $10.49. The company reported Q1 EPS of $0.28 vs $0.11 consensus and revenue of $158.95M vs $146.77M.

Original reporting
Published Jun 1, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 12:19 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cementos Pacasmayo S.A.A. (NYSE:CPAC) Sees Large Growth in Short Interest — source image
Decision brief

The 30-second read

$CPACNeutralMed
01

Why it matters

The main tradable element is the change in short positioning (short interest up sharply in May) rather than new fundamentals; earnings are referenced but not newly reported in this article.

02

Market read

Traders may reassess near-term volatility and risk management for CPAC based on the short-interest jump and days-to-cover.

03

What to watch

Days-to-cover (1.5) is low, implying shorts may not be under heavy pressure; without borrow-rate/CTB or utilization data, squeeze risk is uncertain.

Relevance 7/10Novelty 7/10Timing: positioning update as of May 15; relevant for trading into/after the next few sessions

Background

The article is a short-interest/flow update for CPAC, following an earnings print on April 24.

Company-level read

Ticker impact

$CPACNeutralMedium confidence
Context

Cementos Pacasmayo short interest jumped 121.5% in May, with days-to-cover at 1.5, signaling a fresh positioning/risk shift for CPAC.

Expected impact

Near-term volatility risk slightly higher; directional bias unclear without follow-through on fundamentals or borrow/cover dynamics.

Evidence & confidence

The piece provides a concrete change in short interest and days-to-cover, but lacks catalysts (no new guidance/deal/litigation) and reports ~0.0% shares sold short, limiting conviction on sustained price pressure.

Market effects

Limited direct read-across to cement peers; this is primarily a single-name positioning/flow signal.

Potentially reflects investor sentiment toward Peru-linked construction/materials exposure, but no Peru macro catalyst is cited.

Low—no commodity, FX, or global cement demand shock is described.

Counterpoint

The reported ~0.0% shorted float suggests the short-interest jump may be small in absolute terms, reducing squeeze impact despite the large percentage change.

Key entities

  • Cementos Pacasmayo S.A.A.

    Peru cement and construction materials producer; NYSE-listed CPAC.

Related articles

$GDDYMed

Wall Street Is Losing Confidence in GoDaddy’s (GDDY) AI Strategy. Should Investors?

GoDaddy (NYSE:GDDY) reported Q results of $1.83 EPS and about $1.30B revenue, both above consensus, but the stock fell about 12%. Bookings rose 6% to $1.4B, while Applications and Commerce bookings growth slowed to 7% from 9%. Analysts cited concerns over agentic AI transition noise; management is accelerating Airo and cutting legacy investment. Q3 revenue guidance is $1.32B-$1.34B.

$BAMed

Boeing's 777X Headache Just Got Worse: Lufthansa Says No Thanks

Lufthansa said it will not accept the earliest built examples of Boeing’s 777-9, joining Emirates, as some aircraft have been in storage since 2019-2020. Boeing’s 777X program remains uncertified and is now about 6-7 years behind schedule, with certification targeted for late 2026 or early 2027 and first Lufthansa deliveries in Q1 2027. Boeing took a $4.9B pre-tax charge in 2025.

$DVAMed

DaVita Shares Rise After TD Cowen Upgrades Stock to Buy

DaVita HealthCare Partners (NYSE:DVA) rose about 2.1% premarket after TD Cowen upgraded it from Hold to Buy and raised its price target to $220 from $201, citing improving competitive position and long-term growth. The upgrade followed DaVita’s Q2 2026 results: adjusted EPS $4.02 vs $3.92 expected, revenue about $3.55B vs estimates, while guidance stayed unchanged.

$ONMed

The Numbers Behind ON Semiconductor’s (ON) Higher Target and Unchanged Hold Rating

ON Semiconductor (NASDAQ:ON) reported stronger-than-expected Q2 earnings and issued Q3 guidance above Wall Street expectations. Robert W. Baird analyst Tristan Gerra raised his price target to $108 from $100 and kept a Neutral rating, citing improving AI data center, industrial, EV and China trends and gross margin guidance of 40% to 42%. He flagged potential market-share losses versus TXN and ST.

$BFLYMed

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

Butterfly Network (BFLY) shares rose 24.2% after the company reported Q2 2026 revenue of $32.61M and a reduced net loss of $12.91M, and raised 2026 revenue guidance to $119M to $123M. The article cites improving losses and momentum in Embedded partnerships and enterprise point-of-care ultrasound, while noting ongoing cash burn and potential dilution risks.